Pharmacological and molecular approaches for the treatment of β-hemoglobin disorders
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacological and molecular approaches for the treatment of β-hemoglobin disorders
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR PHYSIOLOGY
Volume 233, Issue 6, Pages 4563-4577
Publisher
Wiley
Online
2017-11-21
DOI
10.1002/jcp.26292
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Gene Therapy for β-Hemoglobinopathies
- (2017) Marina Cavazzana et al. MOLECULAR THERAPY
- Existence of HbF Enhancer Haplotypes atHBS1L-MYBIntergenic Region in Transfusion-Dependent Saudiβ-Thalassemia Patients
- (2017) Cyril Cyrus et al. Biomed Research International
- Customizing the genome as therapy for the β-hemoglobinopathies
- (2016) Matthew C. Canver et al. BLOOD
- Forced chromatin looping raises fetal hemoglobin in adult sickle cells to higher levels than pharmacologic inducers
- (2016) L. Breda et al. BLOOD
- Non-viral delivery of genome-editing nucleases for gene therapy
- (2016) M Wang et al. GENE THERAPY
- Plerixafor and G-CSF combination mobilizes hematopoietic stem and progenitors cells with a distinct transcriptional profile and a reduced in vivo homing capacity compared to plerixafor alone
- (2016) Maria Rosa Lidonnici et al. HAEMATOLOGICA
- Cell and Gene Therapy for the Beta-Thalassemias: Advances and Prospects
- (2016) Jorge Mansilla-Soto et al. HUMAN GENE THERAPY
- Programmable Site-Specific Nucleases for Targeted Genome Engineering in Higher Eukaryotes
- (2016) Ganesan Govindan et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Lineage-specific BCL11A knockdown circumvents toxicities and reverses sickle phenotype
- (2016) Christian Brendel et al. JOURNAL OF CLINICAL INVESTIGATION
- CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells
- (2016) Daniel P. Dever et al. NATURE
- A genome-editing strategy to treat β-hemoglobinopathies that recapitulates a mutation associated with a benign genetic condition
- (2016) Elizabeth A Traxler et al. NATURE MEDICINE
- Chemical Inhibition of Histone Deacetylases 1 and 2 Induces Fetal Hemoglobin through Activation of GATA2
- (2016) Jeffrey R. Shearstone et al. PLoS One
- Genome editing using CRISPR-Cas9 to create the HPFH genotype in HSPCs: An approach for treating sickle cell disease and β-thalassemia
- (2016) Lin Ye et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Transcription factors LRF and BCL11A independently repress expression of fetal hemoglobin
- (2016) T. Masuda et al. SCIENCE
- Selection-free genome editing of the sickle mutation in human adult hematopoietic stem/progenitor cells
- (2016) M. A. DeWitt et al. Science Translational Medicine
- Plerixafor and G-CSF combination mobilizes hematopoietic stem and progenitors cells with a distinct transcriptional profile and a reduced in vivo homing capacity compared to plerixafor alone
- (2016) Maria Rosa Lidonnici et al. HAEMATOLOGICA
- Reactivating Fetal Hemoglobin Expression in Human Adult Erythroblasts Through BCL11A Knockdown Using Targeted Endonucleases
- (2016) Carmen F Bjurström et al. Molecular Therapy-Nucleic Acids
- 563. Generation and Genetic Correction of Patient-Derived Disease-Specific Human Induced Pluripotent Stem Cells Using Gene Editing Nucleases
- (2016) MOLECULAR THERAPY
- The Combination of CRISPR/Cas9 and iPSC Technologies in the Gene Therapy of Human β-thalassemia in Mice
- (2016) Zhanhui Ou et al. Scientific Reports
- Inactivation of HDAC1 or HDAC2 induces gamma globin expression without altering cell cycle or proliferation
- (2015) Erica B. Esrick et al. AMERICAN JOURNAL OF HEMATOLOGY
- Correction of the sickle cell disease mutation in human hematopoietic stem/progenitor cells
- (2015) M. D. Hoban et al. BLOOD
- The LSD1 inhibitor RN-1 induces fetal hemoglobin synthesis and reduces disease pathology in sickle cell mice
- (2015) S. Cui et al. BLOOD
- BCL11A enhancer haplotypes and fetal hemoglobin in sickle cell anemia
- (2015) P. Sebastiani et al. BLOOD CELLS MOLECULES AND DISEASES
- Validation of a novel point of care testing device for sickle cell disease
- (2015) Julie Kanter et al. BMC Medicine
- The Application of CRISPR-Cas9 Genome Editing in Caenorhabditis elegans
- (2015) Suhong Xu Journal of Genetics and Genomics
- BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis
- (2015) Matthew C. Canver et al. NATURE
- Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers
- (2015) Isaac B Hilton et al. NATURE BIOTECHNOLOGY
- HDAC inhibitors still need a home run, despite recent approval
- (2015) Malini Guha NATURE REVIEWS DRUG DISCOVERY
- Epigenetic regulation of fetal globin gene expression in adult erythroid cells
- (2015) Gordon D. Ginder Translational Research
- Editing the genome to introduce a beneficial naturally occurring mutation associated with increased fetal globin
- (2015) Beeke Wienert et al. Nature Communications
- Rewriting the blueprint of life by synthetic genomics and genome engineering
- (2015) Narayana Annaluru et al. GENOME BIOLOGY
- Genetic variants at HbF-modifier loci moderate anemia and leukocytosis in sickle cell disease in Tanzania
- (2014) Siana Nkya Mtatiro et al. AMERICAN JOURNAL OF HEMATOLOGY
- Modulation of gamma globin genes expression by histone deacetylase inhibitors: anin vitrostudy
- (2014) Luisa Ronzoni et al. BRITISH JOURNAL OF HAEMATOLOGY
- TALEN-Mediated Generation and Genetic Correction of Disease-Specific Human Induced Pluripotent Stem Cells
- (2014) Sivaprakash Ramalingam et al. CURRENT GENE THERAPY
- HBS1L-MYB intergenic variants modulate fetal hemoglobin via long-range MYB enhancers
- (2014) Ralph Stadhouders et al. JOURNAL OF CLINICAL INVESTIGATION
- Fetal Globin Gene Repressors as Drug Targets for Molecular Therapies To Treat the -Globinopathies
- (2014) M. Suzuki et al. MOLECULAR AND CELLULAR BIOLOGY
- Whole Exome Sequencing Identifies Novel Genes for Fetal Hemoglobin Response to Hydroxyurea in Children with Sickle Cell Anemia
- (2014) Vivien A. Sheehan et al. PLoS One
- LIN28B-mediated expression of fetal hemoglobin and production of fetal-like erythrocytes from adult human erythroblasts ex vivo
- (2013) Y. T. Lee et al. BLOOD
- CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering
- (2013) Prashant Mali et al. NATURE BIOTECHNOLOGY
- Locus-specific editing of histone modifications at endogenous enhancers
- (2013) Eric M Mendenhall et al. NATURE BIOTECHNOLOGY
- Lysine-specific demethylase 1 is a therapeutic target for fetal hemoglobin induction
- (2013) Lihong Shi et al. NATURE MEDICINE
- Genomic variation in the MAP3K5 gene is associated with β-thalassemia disease severity and hydroxyurea treatment efficacy
- (2013) Christina Tafrali et al. PHARMACOGENOMICS
- MicroRNA-486-3p Regulates γ-Globin Expression in Human Erythroid Cells by Directly Modulating BCL11A
- (2013) Valentina Lulli et al. PLoS One
- Corepressor-dependent silencing of fetal hemoglobin expression by BCL11A
- (2013) J. Xu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- An Erythroid Enhancer of BCL11A Subject to Genetic Variation Determines Fetal Hemoglobin Level
- (2013) D. E. Bauer et al. SCIENCE
- Multiplex Genome Engineering Using CRISPR/Cas Systems
- (2013) L. Cong et al. SCIENCE
- ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering
- (2013) Thomas Gaj et al. TRENDS IN BIOTECHNOLOGY
- The Switch from Fetal to Adult Hemoglobin
- (2013) V. G. Sankaran et al. Cold Spring Harbor Perspectives in Medicine
- The Molecular Basis of -Thalassemia
- (2013) S. L. Thein Cold Spring Harbor Perspectives in Medicine
- Induced Pluripotency for Translational Research
- (2013) Menghua Wu et al. GENOMICS PROTEOMICS & BIOINFORMATICS
- Reawakening fetal hemoglobin: prospects for new therapies for the -globin disorders
- (2012) D. E. Bauer et al. BLOOD
- Epigenetic Alterations in Human Pluripotent Stem Cells: A Tale of Two Cultures
- (2012) Anton Wutz Cell Stem Cell
- KLF10gene expression is associated with high fetal hemoglobin levels and with response to hydroxyurea treatment in β-hemoglobinopathy patients
- (2012) Joseph Borg et al. PHARMACOGENOMICS
- Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria
- (2012) G. Gasiunas et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Heterozygous disruption of human SOX6 is insufficient to impair erythropoiesis or silencing of fetal hemoglobin
- (2011) V. G. Sankaran et al. BLOOD
- Transcriptional regulation of fetal to adult hemoglobin switching: new therapeutic opportunities
- (2011) A. Wilber et al. BLOOD
- A 3-bp deletion in the HBS1L-MYB intergenic region on chromosome 6q23 is associated with HbF expression
- (2011) J. J. Farrell et al. BLOOD
- Site-specific gene correction of a point mutation in human iPS cells derived from an adult patient with sickle cell disease
- (2011) J. Zou et al. BLOOD
- Hydroxyurea for sickle cell anemia: what have we learned and what questions still remain?
- (2011) Patrick T McGann et al. CURRENT OPINION IN HEMATOLOGY
- An integrated approach to dissecting oncogene addiction implicates a Myb-coordinated self-renewal program as essential for leukemia maintenance
- (2011) J. Zuber et al. GENES & DEVELOPMENT
- Nuclear Receptors TR2 and TR4 Recruit Multiple Epigenetic Transcriptional Corepressors That Associate Specifically with the Embryonic -Type Globin Promoters in Differentiated Adult Erythroid Cells
- (2011) S. Cui et al. MOLECULAR AND CELLULAR BIOLOGY
- Correction of Sickle Cell Disease in Adult Mice by Interference with Fetal Hemoglobin Silencing
- (2011) J. Xu et al. SCIENCE
- In Situ Genetic Correction of the Sickle Cell Anemia Mutation in Human Induced Pluripotent Stem Cells Using Engineered Zinc Finger Nucleases
- (2011) Vittorio Sebastiano et al. STEM CELLS
- A Dominant Mutation in the Gene Encoding the Erythroid Transcription Factor KLF1 Causes a Congenital Dyserythropoietic Anemia
- (2010) Lionel Arnaud et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Therapeutic levels of fetal hemoglobin in erythroid progeny of -thalassemic CD34+ cells after lentiviral vector-mediated gene transfer
- (2010) A. Wilber et al. BLOOD
- The inherited diseases of hemoglobin are an emerging global health burden
- (2010) D. J. Weatherall BLOOD
- Update on fetal hemoglobin gene regulation in hemoglobinopathies
- (2010) Daniel E Bauer et al. CURRENT OPINION IN PEDIATRICS
- Correction of β-thalassemia major by gene transfer in haematopoietic progenitors of pediatric patients
- (2010) Emanuela Anna Roselli et al. EMBO Molecular Medicine
- Transcriptional silencing of -globin by BCL11A involves long-range interactions and cooperation with SOX6
- (2010) J. Xu et al. GENES & DEVELOPMENT
- Targeting DNA Double-Strand Breaks with TAL Effector Nucleases
- (2010) M. Christian et al. GENETICS
- Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia
- (2010) Marina Cavazzana-Calvo et al. NATURE
- Haploinsufficiency for the erythroid transcription factor KLF1 causes hereditary persistence of fetal hemoglobin
- (2010) Joseph Borg et al. NATURE GENETICS
- KLF1 regulates BCL11A expression and γ- to β-globin gene switching
- (2010) Dewang Zhou et al. NATURE GENETICS
- Beta-thalassemia
- (2010) Renzo Galanello et al. Orphanet Journal of Rare Diseases
- Chemical genetic strategy identifies histone deacetylase 1 (HDAC1) and HDAC2 as therapeutic targets in sickle cell disease
- (2010) James E. Bradner et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Global distribution of the sickle cell gene and geographical confirmation of the malaria hypothesis
- (2010) Frédéric B. Piel et al. Nature Communications
- The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS)
- (2009) E. Voskaridou et al. BLOOD
- Amelioration of Sardinian 0 thalassemia by genetic modifiers
- (2009) R. Galanello et al. BLOOD
- The HBS1L-MYB intergenic interval associated with elevated HbF levels shows characteristics of a distal regulatory region in erythroid cells
- (2009) K. Wahlberg et al. BLOOD
- A genome-wide association identified the common genetic variants influence disease severity in β0-thalassemia/hemoglobin E
- (2009) Manit Nuinoon et al. HUMAN GENETICS
- Developmental and species-divergent globin switching are driven by BCL11A
- (2009) Vijay G. Sankaran et al. NATURE
- Global epidemiology of haemoglobin disorders and derived service indicators
- (2008) Bernadette Modell BULLETIN OF THE WORLD HEALTH ORGANIZATION
- A T-to-G Transversion at Nucleotide -567 Upstream of HBG2 in a GATA-1 Binding Motif Is Associated with Elevated Hemoglobin F
- (2008) Z. Chen et al. MOLECULAR AND CELLULAR BIOLOGY
- Silencing of A -Globin Gene Expression during Adult Definitive Erythropoiesis Mediated by GATA-1-FOG-1-Mi2 Complex Binding at the -566 GATA Site
- (2008) S. Harju-Baker et al. MOLECULAR AND CELLULAR BIOLOGY
- In vivo selection of genetically modified erythroblastic progenitors leads to long-term correction of -thalassemia
- (2008) A. Miccio et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of -thalassemia
- (2008) M. Uda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- DNA polymorphisms at the BCL11A, HBS1L-MYB, and -globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease
- (2008) G. Lettre et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Fetal Hemoglobin Inducers from the Natural World: A Novel Approach for Identification of Drugs for the Treatment of β-Thalassemia and Sickle-Cell Anemia
- (2007) Nicoletta Bianchi et al. Evidence-based Complementary and Alternative Medicine
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now